They represent enormous levels of expertise that will assist in our mission to make UCS a centre of excellence for translational research and training.
(PRWEB UK) 9 July 2012
UCS has appointed three internationally renowned technologists as Visiting Professors. Dr Chris Tuppen, Dr Nigel Loveridge and Dr Jane Lebkowski will support the development of the School of Science, Technology and Health at UCS, contributing to its research, enterprise, and teaching and learning within their specialised fields.
These latest appointments add to the seventeen prominent Visiting Professors and Senior Fellows already appointed within the School of Science, Technology and Health at UCS and adds further gravitas to its emerging reputation globally as a leading example for research and teaching.
Dr Chris Tuppen, a sustainability expert described by a panel of prominent environmental figures as one of the 50 people who could save the planet from climatic disaster, will bring over twenty years’ experience in sustainability and climate change to his role as Visiting Professor of Smart Technologies. Dr Tuppen, who has a special interest in the application of smart technologies, was previously BT’s Chief Sustainability Officer and has played an active part in a number of prominent public bodies.
Dr Nigel Loveridge, a scientist from Cambridge University Department of Medicine with an international reputation in the field of bone health, is currently Editor in Chief of Cell Biochemistry and Function whose research interests include osteocytes and bone remodelling, an area in which UCS is conducting research within its biotechnology unit - in particular looking into the role of remodelling in the loss of bone strength that occurs during the menopause.
Dr Jane Lebkowski is an internationally renowned stem cell scientist who has pioneered the development of cell-based therapies for use in the treatment of a range of medical conditions including spinal cord injury, heart disease and diabetes. She was Senior Vice President and Chief Scientific Officer of the Regenerative Medicine Division at Geron Corporation where she headed its human stem cell program. Dr Lebkowski serves as the co-chair of the Industrial Committee of the International Society for Stem Cell Research and serves on the editorial boards of several scientific publications, continuing to play lead roles in the development of cell-based therapies in the private sector.
Professor Brendon Noble, Head of School of Science, Technology and Health and an expert in bone diseases, stem cells and regenerative medicine, said of the appointments: “I am delighted that we have appointed these international level scientists to positions in the School. I have had been privileged to work with Professors Lebkowski and Loveridge in the past and look forward to working with Professor Tuppen in the future. They represent enormous levels of expertise that will assist in our mission to make UCS a centre of excellence for translational research and training. In addition to its drive to develop regenerative therapies, the School is also developing it’s capability in SMART systems for use in a wide range of sectors including Health, renewable energy and the bioeconomy.“
The School of Science, Technology and Health at UCS also undertakes research into the areas of Regenerative Medicine, Dementia, Healthcare Delivery Models, Novel Exercise Programmes for an Ageing Population and Virtual Space for Education in the Workplace.